JP2000510109A - 乾燥粉末の吸入方法 - Google Patents
乾燥粉末の吸入方法Info
- Publication number
- JP2000510109A JP2000510109A JP09538984A JP53898497A JP2000510109A JP 2000510109 A JP2000510109 A JP 2000510109A JP 09538984 A JP09538984 A JP 09538984A JP 53898497 A JP53898497 A JP 53898497A JP 2000510109 A JP2000510109 A JP 2000510109A
- Authority
- JP
- Japan
- Prior art keywords
- microns
- drug
- dry powder
- flow rate
- inhalation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 22
- 239000002245 particle Substances 0.000 claims abstract description 34
- 239000003814 drug Substances 0.000 claims abstract description 28
- 229940079593 drug Drugs 0.000 claims abstract description 24
- 239000000203 mixture Substances 0.000 claims abstract description 13
- 239000003517 fume Substances 0.000 claims abstract description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 208000006673 asthma Diseases 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 3
- 239000005556 hormone Substances 0.000 claims description 3
- 230000003204 osmotic effect Effects 0.000 claims description 3
- 229920001184 polypeptide Polymers 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 239000002357 osmotic agent Substances 0.000 claims 1
- 239000003860 topical agent Substances 0.000 claims 1
- 230000008021 deposition Effects 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 11
- 238000001727 in vivo Methods 0.000 description 5
- 229940071648 metered dose inhaler Drugs 0.000 description 5
- 230000002093 peripheral effect Effects 0.000 description 5
- 230000029058 respiratory gaseous exchange Effects 0.000 description 4
- 238000012384 transportation and delivery Methods 0.000 description 4
- 102000055006 Calcitonin Human genes 0.000 description 3
- 108060001064 Calcitonin Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 229960004015 calcitonin Drugs 0.000 description 3
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 3
- 229940112141 dry powder inhaler Drugs 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 229940092705 beclomethasone Drugs 0.000 description 2
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical group CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000003434 inspiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000012385 systemic delivery Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
- A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
- A61M15/0048—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged in a plane, e.g. on diskettes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.a)薬剤粒子寸法が1から7ミクロンであり、供給される煙霧の多量空力 学直径中央値が約3から6ミクロンである乾燥粉末薬剤混合物を準備し、 b)上記粉末薬剤混合物を、ほぼ流速独立性を有し、約10から60L/minの 範囲での吸入流量抵抗が約0.12から0.21(cm H2O)1/2である吸入器に充 填し、 c)約15から60L/minの吸入流速で吸入器から薬剤混合物を吸入し、呼吸 可能な破片が少なくとも20%のである十分な供給を得る 乾燥粉末薬剤の吸入方法。 2.上記薬剤混合物は活性粒子を含み、該活性粒子の空力学的粒子寸法が約4 .5ミクロンである請求項1に記載の方法。 3.上記薬剤は喘息治療用の浸透性又は局所用の薬剤を含む請求項1に記載の 方法。 4.上記薬剤はタンパク質、ポリペプチド又はホルモンを含む請求項1に記載 の方法。 5.5ミクロンを上回る粒子の百分率が約30から90%である請求項1に記 載の方法。 6.上記吸入器は、約0.12から0.18(cm H2O)1/2の流れ抵抗を有する 請求項1に記載の方法。 7.上記薬剤混合物は不活性キャリアを含有する請求項1に記載の方法。 8.上記薬剤はベクラメサゾンを備える請求項1に記載の方法。 9.呼吸可能な破片(約5.8ミクロンを下回る粒子寸法で衝突式収集器)の 入口に突入する粒子破片)が少なくとも20%である請求項1に記載の方法。 10.15から60L/minの範囲で流れ抵抗が約0.12から0.21(cm H2 O)1/2である請求項1に記載の方法。 11.供給される煙霧の多量空力学直径中央値が約3.5から5.5ミクロン である請求項1に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1642896P | 1996-04-29 | 1996-04-29 | |
US60/016,428 | 1996-04-29 | ||
PCT/US1997/006621 WO1997040819A1 (en) | 1996-04-29 | 1997-04-21 | Methods of dry powder inhalation |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009040744A Division JP2009148586A (ja) | 1996-04-29 | 2009-02-24 | 乾燥粉末薬剤の吸入システム |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2000510109A true JP2000510109A (ja) | 2000-08-08 |
Family
ID=21777075
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP09538984A Pending JP2000510109A (ja) | 1996-04-29 | 1997-04-21 | 乾燥粉末の吸入方法 |
JP2009040744A Pending JP2009148586A (ja) | 1996-04-29 | 2009-02-24 | 乾燥粉末薬剤の吸入システム |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009040744A Pending JP2009148586A (ja) | 1996-04-29 | 2009-02-24 | 乾燥粉末薬剤の吸入システム |
Country Status (16)
Country | Link |
---|---|
US (1) | US6116237A (ja) |
EP (1) | EP0896525B1 (ja) |
JP (2) | JP2000510109A (ja) |
AT (1) | ATE247948T1 (ja) |
AU (1) | AU724503B2 (ja) |
BR (1) | BR9709748A (ja) |
CA (1) | CA2252814A1 (ja) |
CZ (1) | CZ343798A3 (ja) |
DE (1) | DE69724420T2 (ja) |
DK (1) | DK0896525T3 (ja) |
ES (1) | ES2205210T3 (ja) |
HU (1) | HUP9901575A3 (ja) |
IL (1) | IL126701A (ja) |
NO (1) | NO984999D0 (ja) |
NZ (1) | NZ332669A (ja) |
WO (1) | WO1997040819A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009148586A (ja) * | 1996-04-29 | 2009-07-09 | Quadrant Technologies Ltd | 乾燥粉末薬剤の吸入システム |
Families Citing this family (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6060069A (en) * | 1991-05-20 | 2000-05-09 | Dura Pharmaceuticals, Inc. | Pulmonary delivery of pharmaceuticals |
US6681767B1 (en) * | 1991-07-02 | 2004-01-27 | Nektar Therapeutics | Method and device for delivering aerosolized medicaments |
EP0940154B1 (en) * | 1991-07-02 | 2007-04-18 | Nektar Therapeutics | Device for delivering aerosolized medicaments |
CA2200727C (en) | 1994-09-21 | 2006-11-28 | Adrian E. Smith | Apparatus and methods for dispersing dry powder medicaments |
US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
OA11529A (en) | 1998-03-16 | 2004-05-07 | Inhale Therapeutic Syst | Aerosolized active agent delivery. |
US6257233B1 (en) * | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
US7056504B1 (en) | 1998-08-27 | 2006-06-06 | Massachusetts Institute Of Technology | Rationally designed heparinases derived from heparinase I and II |
UA73924C2 (en) | 1998-10-09 | 2005-10-17 | Nektar Therapeutics | Device for delivering active agent formulation to lungs of human patient |
JP2000217917A (ja) * | 1999-01-27 | 2000-08-08 | Unisia Jecs Corp | 吸入式投薬器 |
WO2000065521A2 (en) | 1999-04-23 | 2000-11-02 | Massachusetts Institute Of Technology | System and method for polymer notation |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
US6606992B1 (en) | 1999-06-30 | 2003-08-19 | Nektar Therapeutics | Systems and methods for aerosolizing pharmaceutical formulations |
US7464706B2 (en) * | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
US7305986B1 (en) | 1999-07-23 | 2007-12-11 | Mannkind Corporation | Unit dose capsules for use in a dry powder inhaler |
WO2001066772A2 (en) * | 2000-03-08 | 2001-09-13 | Massachusetts Institute Of Technology | Heparinase iii and uses thereof |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
WO2001085136A2 (en) | 2000-05-10 | 2001-11-15 | Alliance Pharmaceutical Corporation | Phospholipid-based powders for drug delivery |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
WO2002013897A2 (en) | 2000-08-14 | 2002-02-21 | Advanced Inhalation Research, Inc. | Inhalation device and method |
JP4911865B2 (ja) | 2000-09-12 | 2012-04-04 | マサチューセッツ インスティテュート オブ テクノロジー | 低分子量ヘパリンに関連する方法および生成物 |
CA2423469A1 (en) | 2000-10-18 | 2002-04-25 | Massachusetts Institute Of Technology | Methods and products related to pulmonary delivery of polysaccharides |
ATE299729T1 (de) * | 2001-03-15 | 2005-08-15 | Us Gov Health & Human Serv | Vernebler mit kühlkammer |
US6766799B2 (en) * | 2001-04-16 | 2004-07-27 | Advanced Inhalation Research, Inc. | Inhalation device |
US7766013B2 (en) | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
US6737042B2 (en) * | 2001-05-24 | 2004-05-18 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
JP4261351B2 (ja) | 2001-09-19 | 2009-04-30 | アドヴェント ファーマセウティカルズ プロプライエタリー リミテッド | 吸入器 |
ATE508735T1 (de) | 2001-12-19 | 2011-05-15 | Novartis Ag | Pulmonale verabreichung von aminoglykosiden |
GB0201677D0 (en) * | 2002-01-25 | 2002-03-13 | Glaxo Group Ltd | Medicament dispenser |
GB0217199D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
US6705316B2 (en) | 2002-03-11 | 2004-03-16 | Battelle Pulmonary Therapeutics, Inc. | Pulmonary dosing system and method |
DE60226509D1 (de) * | 2002-03-20 | 2008-06-19 | Alkermes Inc | Inhalationsgerät für pulverförmige substanzen |
ES2425392T3 (es) | 2002-03-20 | 2013-10-15 | Mannkind Corporation | Cartucho para un aparato de inhalación |
US7185651B2 (en) * | 2002-06-18 | 2007-03-06 | Nektar Therapeutics | Flow regulator for aerosol drug delivery and methods |
WO2004011067A1 (en) * | 2002-07-25 | 2004-02-05 | Glaxo Group Limited | Medicament dispenser |
AU2003254590A1 (en) * | 2002-07-25 | 2004-02-16 | Glaxo Group Limited | Medicament dispenser |
GB0217198D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
GB0217196D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
US7913688B2 (en) * | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
GB0308771D0 (en) * | 2003-04-16 | 2003-05-21 | Univ Loughborough | Pulmonary drug delivery |
CN100381083C (zh) | 2003-04-29 | 2008-04-16 | 韩力 | 一种非可燃性电子喷雾香烟 |
WO2004104490A1 (en) | 2003-05-21 | 2004-12-02 | Alexza Pharmaceuticals, Inc. | Self-contained heating unit and drug-supply unit employing same |
GB0313604D0 (en) * | 2003-06-12 | 2003-07-16 | Britannia Pharmaceuticals Ltd | Delivery device for powdered medicament |
GB0317374D0 (en) * | 2003-07-24 | 2003-08-27 | Glaxo Group Ltd | Medicament dispenser |
EP1699434B1 (en) * | 2003-09-02 | 2011-02-16 | Norton Healthcare Limited | Process for preparing a medicament |
GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
US20050256073A1 (en) | 2004-02-19 | 2005-11-17 | Coley Pharmaceutical Group, Inc. | Immunostimulatory viral RNA oligonucleotides |
CA2561845C (en) * | 2004-04-02 | 2014-03-25 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Aerosol delivery systems and methods |
EP1744800B1 (en) | 2004-04-21 | 2016-06-22 | Innovata Biomed Limited | Inhaler |
GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
GB0418278D0 (en) | 2004-08-16 | 2004-09-15 | Glaxo Group Ltd | Medicament dispenser |
CN101010305B (zh) | 2004-08-20 | 2010-08-11 | 曼金德公司 | 二酮哌嗪合成的催化反应 |
KR101644250B1 (ko) | 2004-08-23 | 2016-07-29 | 맨카인드 코포레이션 | 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염 |
CN100522274C (zh) * | 2004-09-16 | 2009-08-05 | 詹皮耶罗·科西 | 用于粉末药剂的一次性单次剂量吸入器 |
US8337815B2 (en) * | 2004-12-23 | 2012-12-25 | Discovery Laboratories, Inc. | Pulmonary surfactant formulations |
GB0515584D0 (en) * | 2005-07-28 | 2005-09-07 | Glaxo Group Ltd | Medicament dispenser |
AU2006290227B2 (en) | 2005-09-14 | 2012-08-02 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
WO2007095316A2 (en) | 2006-02-15 | 2007-08-23 | Coley Pharmaceutical Gmbh | Compositions and methods for oligonucleotide formulations |
DK1986679T3 (da) | 2006-02-22 | 2017-11-20 | Mannkind Corp | Fremgangsmåde til forbedring af mikropartiklers farmaceutiske egenskaber omfattende diketopiperazin og et aktivt indholdsstof |
GB0622827D0 (en) * | 2006-11-15 | 2006-12-27 | Glaxo Group Ltd | Sheet driver for use in a drug dispenser |
WO2008112661A2 (en) | 2007-03-09 | 2008-09-18 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
US8496002B2 (en) * | 2007-06-12 | 2013-07-30 | Civitas Therapeutics, Inc. | Powder inhaler devices |
CN101795721B (zh) | 2007-06-15 | 2013-12-25 | 贝林格尔.英格海姆国际有限公司 | 吸入器 |
EP2082762A1 (en) * | 2008-01-24 | 2009-07-29 | Boehringer Ingelheim International Gmbh | Inhaler |
WO2009121020A1 (en) * | 2008-03-27 | 2009-10-01 | Mannkind Corporation | A dry powder inhalation system |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
CA2728230C (en) | 2008-06-13 | 2017-10-17 | Mannkind Corporation | A dry powder inhaler and system for drug delivery |
AU2009259883B2 (en) | 2008-06-20 | 2015-02-05 | Mannkind Corporation | An interactive apparatus and method for real-time profiling of inhalation efforts |
TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
ES2570128T3 (es) | 2008-09-26 | 2016-05-17 | Oriel Therapeutics Inc | Inhaladores con discos que tienen conductos de aire equipados con canales discretos de conductos de aire y discos y métodos relacionados |
KR101650075B1 (ko) | 2008-09-26 | 2016-08-22 | 오리엘 테라퓨틱스, 인크. | 이중 관통 부재들을 구비한 건조 분말 흡입기, 및 그와 관련된 장치 및 방법 |
WO2010039202A2 (en) * | 2008-10-01 | 2010-04-08 | Oriel Therapeutics, Inc. | Dry powder inhalers with rotating piercing mechanisms and related devices and methods |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
KR101257597B1 (ko) | 2009-02-23 | 2013-04-26 | 니뽄 다바코 산교 가부시키가이샤 | 비가열형 담배 향미 흡인기 |
US8538707B2 (en) * | 2009-03-11 | 2013-09-17 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
SG176738A1 (en) | 2009-06-12 | 2012-01-30 | Mannkind Corp | Diketopiperazine microparticles with defined specific surface areas |
WO2011039646A2 (en) | 2009-09-30 | 2011-04-07 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Papilloma virus -like particles for targeted gene delivery |
EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
EP2582421A1 (en) | 2010-06-21 | 2013-04-24 | MannKind Corporation | Dry powder drug delivery system and methods |
ES2625858T3 (es) | 2011-04-01 | 2017-07-20 | Mannkind Corporation | Paquete de tipo blíster para cartuchos farmacéuticos |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
CA2852536A1 (en) | 2011-10-24 | 2013-05-02 | Mannkind Corporation | Methods and compositions for treating pain |
WO2014012069A2 (en) | 2012-07-12 | 2014-01-16 | Mannkind Corporation | Dry powder drug delivery systems and methods |
KR101466616B1 (ko) * | 2012-10-11 | 2014-11-28 | 한미약품 주식회사 | 건조분말 흡입장치 |
EP2911690A1 (en) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalable influenza vaccine compositions and methods |
BR112015010601B1 (pt) | 2012-11-09 | 2022-07-19 | Civitas Therapeutics, Inc. | Composição farmacêutica e uso da composição |
US8545878B1 (en) | 2012-11-09 | 2013-10-01 | Civitas Therapeutics, Inc. | Capsules containing high doses of levodopa for pulmonary use |
US10034988B2 (en) * | 2012-11-28 | 2018-07-31 | Fontem Holdings I B.V. | Methods and devices for compound delivery |
EP3587404B1 (en) | 2013-03-15 | 2022-07-13 | MannKind Corporation | Microcrystalline diketopiperazine compositions, methods for preparation and use thereof |
BR112016000937A8 (pt) | 2013-07-18 | 2021-06-22 | Mannkind Corp | formulações farmacêuticas de pó seco, método para a fabricação de uma formulação de pó seco e uso de uma formulação farmacêutica de pó seco |
EP3030294B1 (en) | 2013-08-05 | 2020-10-07 | MannKind Corporation | Insufflation apparatus |
WO2015042412A1 (en) | 2013-09-20 | 2015-03-26 | E-Nicotine Technology. Inc. | Devices and methods for modifying delivery devices |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
CN107847696B (zh) | 2014-09-10 | 2020-11-06 | 方特慕控股第一私人有限公司 | 用于调节递送装置中的气流的方法和装置 |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
CN107106641B (zh) | 2014-10-31 | 2021-12-21 | 葛兰素史密斯克莱知识产权发展有限公司 | 粉末制剂 |
KR20180065970A (ko) | 2015-01-22 | 2018-06-18 | 폰템 홀딩스 1 비.브이. | 전자 증발 장치 |
IT201600093878A1 (it) | 2016-09-19 | 2018-03-19 | Hollycon Italy Pte Ltd S R L | Inalatore monodose a perdere per medicinali in polvere |
WO2018071443A1 (en) | 2016-10-11 | 2018-04-19 | Microdose Therapeutx, Inc. | Inhaler and methods of use thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994013271A1 (en) * | 1992-12-11 | 1994-06-23 | Astra Aktiebolag | System for dispensing pharmaceutically active compounds |
WO1994017784A1 (en) * | 1993-02-04 | 1994-08-18 | Amgen Inc. | Pulmonary administration of erythropoietin |
JPH0753358A (ja) * | 1993-08-17 | 1995-02-28 | Teijin Ltd | 吸入剤 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB248400A (ja) * | 1925-02-28 | 1926-11-18 | Societe Francaise Des Films Herault | |
US3831606A (en) * | 1971-02-19 | 1974-08-27 | Alza Corp | Auto inhaler |
IT1220979B (it) * | 1981-06-04 | 1990-06-21 | Lofarma Farma Lab | Capsule contenenti un allergene e procedimento per la loro preparazione |
GB8432063D0 (en) * | 1984-12-19 | 1985-01-30 | Riker Laboratories Inc | Physically modified steroids |
EP0705614B1 (en) * | 1989-04-28 | 2002-09-25 | Riker Laboratories, Inc. | Dry powder inhalation device |
US5176132A (en) * | 1989-05-31 | 1993-01-05 | Fisons Plc | Medicament inhalation device and formulation |
US5327883A (en) * | 1991-05-20 | 1994-07-12 | Dura Pharmaceuticals, Inc. | Apparatus for aerosolizing powdered medicine and process and using |
US5492112A (en) * | 1991-05-20 | 1996-02-20 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
US5469843A (en) * | 1991-11-12 | 1995-11-28 | Minnesota Mining And Manufacturing Company | Inhalation device |
CA2147260C (en) * | 1992-10-19 | 1999-04-13 | Mark Bernard Mecikalski | Dry powder inhaler |
US5792057A (en) * | 1993-05-21 | 1998-08-11 | Aradigm Corporation | Ventilation imaging using a fine particle aerosol generator |
US5388574A (en) * | 1993-07-29 | 1995-02-14 | Ingebrethsen; Bradley J. | Aerosol delivery article |
US5524613A (en) * | 1993-08-25 | 1996-06-11 | Habley Medical Technology Corporation | Controlled multi-pharmaceutical inhaler |
US5522385A (en) * | 1994-09-27 | 1996-06-04 | Aradigm Corporation | Dynamic particle size control for aerosolized drug delivery |
US5503869A (en) * | 1994-10-21 | 1996-04-02 | Glaxo Wellcome Inc. | Process for forming medicament carrier for dry powder inhalator |
US5645051A (en) * | 1995-04-21 | 1997-07-08 | Dura Pharmaceuticals, Inc. | Unit dose dry powder inhaler |
US5622166A (en) * | 1995-04-24 | 1997-04-22 | Dura Pharmaceuticals, Inc. | Dry powder inhaler delivery system |
CZ343798A3 (cs) * | 1996-04-29 | 1999-02-17 | Dura Pharmaceuticals, Inc. | Inhalační systém pro inhalaci suchého prášku |
-
1997
- 1997-04-21 CZ CZ983437A patent/CZ343798A3/cs unknown
- 1997-04-21 HU HU9901575A patent/HUP9901575A3/hu unknown
- 1997-04-21 CA CA002252814A patent/CA2252814A1/en not_active Abandoned
- 1997-04-21 JP JP09538984A patent/JP2000510109A/ja active Pending
- 1997-04-21 WO PCT/US1997/006621 patent/WO1997040819A1/en active IP Right Grant
- 1997-04-21 AT AT97921298T patent/ATE247948T1/de active
- 1997-04-21 ES ES97921298T patent/ES2205210T3/es not_active Expired - Lifetime
- 1997-04-21 DK DK97921298T patent/DK0896525T3/da active
- 1997-04-21 BR BR9709748-9A patent/BR9709748A/pt not_active IP Right Cessation
- 1997-04-21 IL IL12670197A patent/IL126701A/en not_active IP Right Cessation
- 1997-04-21 DE DE69724420T patent/DE69724420T2/de not_active Expired - Lifetime
- 1997-04-21 EP EP97921298A patent/EP0896525B1/en not_active Revoked
- 1997-04-21 NZ NZ332669A patent/NZ332669A/xx unknown
- 1997-04-21 AU AU27371/97A patent/AU724503B2/en not_active Ceased
- 1997-04-24 US US08/847,287 patent/US6116237A/en not_active Expired - Lifetime
-
1998
- 1998-10-27 NO NO984999A patent/NO984999D0/no not_active Application Discontinuation
-
2009
- 2009-02-24 JP JP2009040744A patent/JP2009148586A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994013271A1 (en) * | 1992-12-11 | 1994-06-23 | Astra Aktiebolag | System for dispensing pharmaceutically active compounds |
WO1994017784A1 (en) * | 1993-02-04 | 1994-08-18 | Amgen Inc. | Pulmonary administration of erythropoietin |
JPH0753358A (ja) * | 1993-08-17 | 1995-02-28 | Teijin Ltd | 吸入剤 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009148586A (ja) * | 1996-04-29 | 2009-07-09 | Quadrant Technologies Ltd | 乾燥粉末薬剤の吸入システム |
Also Published As
Publication number | Publication date |
---|---|
DE69724420T2 (de) | 2004-06-09 |
NZ332669A (en) | 1999-02-25 |
WO1997040819A1 (en) | 1997-11-06 |
CA2252814A1 (en) | 1997-11-06 |
CZ343798A3 (cs) | 1999-02-17 |
NO984999L (no) | 1998-10-27 |
NO984999D0 (no) | 1998-10-27 |
AU724503B2 (en) | 2000-09-21 |
IL126701A (en) | 2001-08-08 |
DK0896525T3 (da) | 2003-12-01 |
EP0896525B1 (en) | 2003-08-27 |
AU2737197A (en) | 1997-11-19 |
HUP9901575A3 (en) | 1999-11-29 |
EP0896525A4 (en) | 2001-01-10 |
US6116237A (en) | 2000-09-12 |
EP0896525A1 (en) | 1999-02-17 |
HUP9901575A2 (hu) | 1999-08-30 |
ATE247948T1 (de) | 2003-09-15 |
BR9709748A (pt) | 2000-01-11 |
ES2205210T3 (es) | 2004-05-01 |
JP2009148586A (ja) | 2009-07-09 |
DE69724420D1 (de) | 2003-10-02 |
IL126701A0 (en) | 1999-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000510109A (ja) | 乾燥粉末の吸入方法 | |
US5934273A (en) | System for dispensing pharmaceutically active compounds | |
EP0257956B2 (en) | Use of polypeptide growth factors and cytokines for the manufacture of a device and of a dispersion | |
JP4378057B2 (ja) | 流動抵抗調節されたエアロゾル化活性薬剤送達 | |
US6250300B1 (en) | System for dispensing pharmaceutically active compounds | |
US6951215B1 (en) | Drug delivery device for animals | |
US20020144680A1 (en) | Method and device for releasing powder | |
JP2002532537A (ja) | 肺への薬物送達 | |
RU2002134467A (ru) | Способ высокоэффективной доставки аэрозоля с большой терапевтической массой | |
JPH08508439A (ja) | スペーサー | |
JP2003503116A (ja) | 吸入器 | |
JP2001527442A (ja) | ハロセラピーの投与方法 | |
WO2004110539A1 (en) | Administration of medicinal dry powders | |
EP3941438A1 (en) | Inhalable dry powders | |
Hilman | Aerosol deposition and delivery of therapeutic aerosols | |
O'Callaghan | Targeting drug delivery to the lungs by inhalation | |
WO2004110491A1 (en) | Combined doses | |
EP1110547A2 (en) | Helium and neon as means delivering drug in inhaler | |
MXPA98008976A (en) | Methods for inhalation of dusts se | |
Ganderton | Patients, devices and formulations | |
Elwood | Extrafine CFC-free beclomethasone aerosol hits the right spot | |
Tattersfield et al. | Methods of Drug Administration | |
CZ375599A3 (cs) | Způsob podávání haloterapie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040414 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20041104 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080115 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080410 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080526 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080515 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20081028 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090224 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20090409 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20090813 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120118 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120127 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120425 |